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Abstract
Oral administration of royal jelly (RJ) promotes wound healing in diabetic mice. Concerns have arisen regarding the efficacy of RJ on the wound
healing process of normal skin cells. In this study, a wound was created by scratching normal human dermal fibroblasts, one of the major cells
involved in the wound healing process. The area was promptly treated with RJ at varying concentrations of 0.1, 1.0, or 5 mg/ml for up to 48 
hrs and migration was analyzed by evaluating closure of the wound margins. Furthermore, altered levels of lipids, which were recently reported 
to participate in the wound healing process, were analyzed by HPTLC and HPLC. Migration of fibroblasts peaked at 24 hrs after wounding. RJ 
treatment significantly accelerated the migration of fibroblasts in a dose-dependent manner at 8 hrs. Although RJ also accelerated the migration
of fibroblasts at both 20 hrs and 24 hrs after wounding, the efficacy was less potent than at 8 hrs. Among various lipid classes within fibroblasts,
the level of cholesterol was significantly decreased at 8 hrs following administration of both 0.1 ug/ml and 5 mg/ml RJ. Despite a dose-dependent
increase in sphinganines, the levels of sphingosines, ceramides, and glucosylceramides were not altered with any concentration of RJ. We demonstrated
that RJ enhances the migration of fibroblasts and alters the levels of various lipids involved in the wound healing process.
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Introduction3)
Royal jelly (RJ), a secretion of the hypo-pharyngeal and 
mandibular glands of worker honey bees, is a health tonic widely 
consumed with various perceived benefits [1]. RJ has been used 
since ancient times as a remedy for wound healing [2]. However, 
although the results from a randomized clinical trial document 
that RJ accelerates wound healing, no study has been performed 
regarding the influence of RJ on human skin cells, including 
dermal fibroblasts. Several studies demonstrate that oral 
administration of RJ promotes wound healing in diabetic mice 
through anti-inflammatory effects and by enhancing the 
formation of granular tissue. Concerns have arisen regarding the 
efficacy of RJ in the wound healing process of normal skin cells. 
Through intensive studies on various in vitro and animal models, 
the wound healing enhancing effects of RJ have been demonstrated 
[2-8]. Wound healing of the skin is a complex process that 
involves an inflammatory response, new tissue formation, and 
remodeling of the extracellular matrix [3]. After the initial 
inflammatory response, new tissue formation begins with migration 
and proliferation of keratinocytes at the wound edge, followed 
by migration of dermal fibroblasts into the area of the wound where 
they proliferate and deposit extracellular matrix [9]. Throughout 
the wound healing process, fibroblasts, as well as inflammatory 
cells, produce various growth factors, cytokines, and mitogens 
that play intertwined and important roles in wound closure [9]. 
Recent evidence indicates that increased lipid biosynthesis may 
also enhance wound healing closure and restoration of the barrier 
function of the skin during the wound healing process. The skin 
barrier is formed from the lipid- enriched membrane of the 
stratum corneum, which is the outer most layer of the epidermis, 
and is organized with a repetitive lamellar structure of sphingolipids, 
cholesterol, and fatty acids [3,10]. Reduced lipid synthesis delays 
wound healing [11] and enhanced wound closure with an 
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increased level of skin barrier lipids has been reported during 
the wound healing process of skin [11,12]. 
In this study, we investigate if RJ treatment accelerates the 
migration of dermal fibroblasts, one of the major cells involved 
in granular tissue formation during wound healing. Furthermore, 
we determine whether RJ treatment alters the levels of lipids 
in fibroblast; such alterations have recently been reported to aid 
in wound closure. Our data presented herein demonstrate that 
RJ enhances the migration of fibroblasts and alters the levels 
of various lipids involved in the wound healing process. 
Materials and Methods
Materials
Normal human dermal fibroblast (neonatal; C-004-5C) (HDFn) 
growth supplement was purchased from Cascade Biologics 
(Portland, OR, USA). Cell culture media including Dulbecco's 
modified Eagle's medium (DMEM) and fetal bovine serum (FBS) 
were obtained from Gibco BRL (Gathersburg, MD, USA). 
Mytocin C was purchased from Sigma-Aldrich (St. Louis, MO, 
USA). High-performance thin layer chromatography (HPTLC) 
plates (Silca Gel 60) were purchased from Merck (Dermstadt, 
Germany). High-performance liquid chromatography (HPLC; 
Agilent 1100 series) was performed using a C18 reversed-phase 
column (symmetry C18 5 μm 4.6 mm × 150 mm column; Milford 
MA. USA). 
RJ
RJ collected in Korea was used throughout the experiments. 
The RJ was suspended in sterile phosphate-buffered saline (PBS). 
Prior to treatment, the cells were dissolved in a DMSO 
concentration at 1 mg/ml. The RJ suspension was then divided 
into aliquots and stored at -80℃ until administration. No bacteria 
colony formation was observed in these RJ suspensions as 
examined by a standard agar plate culture assay [13]. The 
endotoxin content of the RJ was < 50 pg/mg as measured by 
a  Limulus amebocyte lysate assay (Seikagaku Kogyo, Tokyo, 
Japan) [14].
Cell cultures 
Fibroblasts: Human dermal fibroblasts (HDFn) were isolated 
from neonatal foreskin. Primary cultures of HDFn were grown 
from human dermal fibroblast tissue removed at the time of 
reduction mammoplasty and were used at passage 2-15 in 
primary cultures of diabetic mice. Fibroblasts were prepared from 
the diabetic mice and were used at passage 3-10. The HDFn 
were maintained in DMEM containing 10% fetal bovine serum 
(FBS) (Gibco, Grand Island, NY) and 1% penicillin-streptomycin. 
Cells were incubated at 37℃ in 5% CO2  [15,16]. 
Cell viability by MTT assays 
Cytotoxicity was assessed using a 3-[4,5-dimethylthiazol-2-yl]- 
2,5-diphenyltetrazolium bromide (MTT) assay [17,18]. HDFn 
cells were seeded in 96-well plates and treated with various 
concentrations of RJ. They were cultured in a 5% CO2 incubator 
for the indicated periods. After removing the media, MTT (0.5 
mg/ml) was added and incubated at 37℃ for 2 hrs. Supernatants 
were carefully discarded and 1 ml of DMSO was added. After 
incubating at 25℃ for 30 min, the reactants were measured by 
a microplate reader (UV max, Molecular Devices, USA) at 570 
nm.
Cell migration assay 
Cells were grown to 60% confluence in 6-well plates. To 
eliminate cell proliferation, all cells were pretreated with 10 
ug/ml mitomycin C (Sigma, MO) for 1 hr and washed with PBS 
prior to scratching. The scratchings were performed by scraping 
with a sterile rubber policeman. The wound margins were 
photographed at time t = 0 under a microscope (Motic AE31: 
Motic Instrument Inc, Richmond, BC, Canada) using a digital 
camera (Moticam 1300: Motic Instrument Inc, Richmond, BC, 
Canada) [19]. Cells were treated for up to 48 hrs with cell media 
only (control) or with 0.1 ug/ml, 1 ug/ml, or 5 ug/ml of RJ 
dissolved in cell media. The wounds were subsequently 
re-photographed in the same field at different time points. The 
experiments were performed in triplicate for each of four 
independent trials. Cell migration was analyzed by image J 
(image processing and analysis in Java by NIH image: http://rsb. 
info.nih.govij/) and expressed as percent wound coverage by cells 
moving into the scratched wound area at different time points. 
The concentration range of RJ (0.1-5 ug/ml) was based on RJ 
concentration with > 90% cell viability by MTT assay (Promega, 
Madison, WI, USA) in a preliminary experiment (data not 
shown). Cell migration data were expressed as percent wound 
coverage. 
Lipid composition analysis 
A. HPTLC 
The cells in the wounds were treated for 8 hrs with RJ at 
varying concentrations of 0.1 ug/ml, 1 ug/ml, or 5 ug/ml. The 
treated cells were placed in 0.24% HCl in methanol and crushed 
with a polytron. The resulting solution (chloroform/methanol, 1:1 
v/v) was combined with the 3 N NaOH supernatant and the 
sphingosine content was analyzed. The component lipids were 
then separated using HPTLC on 10 × 10 cm silica gel plates 
(Merck, Darmastdt, Germany). To aid in separation, the lower 
portion was added to a mixture of choloroform: 1 M NaCl (1:1, 
v/v) and 3 N NaOH. The lower part of the solution containing 
0.15 M KOH in methanol was then added. HPTLC analysis of 
the lower portion of the generated mixture was used in this 364 Royal jelly enhances wound healing process
Fig. 1. Viability of cells treated with RJ as measured by the MTT assay. Values 
are  mean ± SE.
experiment. 
Ceramide, glucosylceramide (GC), triglyceride (TG), and 
cholesterol deployment conditions were as follows: the spotting 
volume was 20 ul for all lanes; the plates were chromatograph 
in the 10 cm dimension; the receptacles were TLC tanks (6 × 
12 × 3.75 cm in; Analabs, North Haven, CT) lined with filter 
paper; solvent systems (approximately 100 ml total) were 
equilibrated several hours before use; and lipids were measured 
by spotting lipid extracts and lipid standards (Sigma. Co., St. 
Louis. MO.) on the plates and separating them using a semi- 
automatic operator (Limonat 5, Merck, Darmaster, Germany). 
The first development was carried out in a chloroform: methanol: 
H2O (40:10:1, v/v/v) mixture until the solvent front had migrated 
approximately 2.5 cm. Following development, excess solvent 
was evaporated in a fume hood for 15 min and then in a vacuum 
desiccator for 15 min. The second development was performed 
in a chloroform: methanol: acetic acid (40:10:1, v/v/v) mixture 
until the solvent front had migrated approximately 5 cm. The 
second development was repeated (third development). The front 
development was carried out in n-hexane: diethyl ether: acetic 
acid (65:35:1, v/v/v) until the solvent front had migrated 
approximately 8.5 cm [20]. Excess solvent was evaporated as 
described above. Plates were sprayed with a 0.25% sodium 
dichromate (w/v) 15% sulfuric acid (v/v) reagent and heated for 
30 min at 120℃ and then dipped into a 3% cupric acetate (w/v) 
8% phosphoric acid (v/v) solution and either heated at 180℃ 
for 15 min or at 130℃ for 30 min. All plates were either heated 
on an aluminum block (20 × 20 × 2.5 cm) set on a hot plate (130 
℃) or placed in a hot air oven (180℃). Plates were either scanned 
immediately after heating, or stored at -20℃ and scanned within 
24 hrs. Finally, the HPTLC plates were cooled to room 
temperature and the lipid samples were quantified by 
photodensitometry at 254 nm using the CAMAG HPTLC scanner 
Ⅲ  (CAMAG, Muttenz, Switzerland). Analytic data were 
processed by computer using the CAMAG HPTLC program 
(WINCAT software, version 2.2) [21]. 
B. HPLC
The hydroxyl fatty acids from the HDFn homogenate were 
placed in an ice-cold chloroform:methanol (2:1, v/v) solution 
after acidification to a pH of 3.0. Next, 10 ml of a RIPA buffer 
(20 mM Tris-HCl, pH 3.0, 150 mM NaCl, 10 mM NaPO4, 10% 
glycerol, 10M Na3VO4, 100M ammonium molybdate, 1% NP-40, 
0.1% SDS) was added to the HDFn. This mixture was then 
pulverized with a polytron. An equivalent amount of Folch 
solution [22] was added to the pulverized samples, the resulting 
mixture was then centrifuged (3,000 rpm, 5 min). The lower part 
of the solution was collected, dried with nitrogen gas, and 
dissolved in 20 ul of methanol. The hydroxyl fatty acids from 
the HDFn were then subjected to reverse phase HPLC 
(RP-HPLC) using a Beckman 5 um octadecylsilica (ODS 18) 
column (symmetry C18 5 μm 4.6 mm × 150 mm column; Milford 
MA. USA) as reported previously [23]. The chromatographic 
system was run isocratically at a flow rate of 1.0 ml/min on 
a Waters Breeze HPLC system (515 HPLC pump with UV/vis 
Detector, Waters, Inc., U.S.A.). The mobile phase solvents were 
74% methanol and 26% H2O containing 0.8 g/L acetic acid. A 
photo-diode array detector with a UV absorption spectrum (2996 
PDA Dectector, Waters, Co, U.S.A.) was used to confirm the 
purification of separated hydroxyl fatty acids from each sample 
in the presence of an analytically useful absorption band, with 
Amax = 238 nm (€ 238 = 28,000/M/cm). The level of hydroxyl 
fatty acids in each sample was quantified using external standards 
of sphinganine and sphingosine. A calibration curve with the 
various concentrations of the external standards revealed good 
linearity, with R2 values exceeding 0.99 (peak area vs 
concentration). The detection limit for each external standard was 
2 mg/L. 
Statistical analysis
The data were subjected to one way analysis of variance 
(ANOVA) to determine overall differences between the groups. 
Differences with P< 0.05 were considered statistically significant.
Results
Effects of RJ on cell viability of HDFn 
The effects of RJ on the cell survival of the HDFn are shown 
in Fig. 1. RJ dose-dependence and cell viability were determined 
using MTT assay results (Fig. 1). 
Effects of RJ on cell migration of HDFn 
When the in vitro migration assay was performed with 
fibroblasts, > 100% of wound coverage was achieved with 
fibroblasts (Fig. 2) at 48 hrs after wound scratching. When 1 
ug/ml or 5 ug/ml RJ was applied for 8 hrs after wound scratching, Juyoung Kim et al. 365
A.
B.
Fig. 2. RJ induced migration of human dermal fibroblasts in an in vitro wound 
models. (A) Human  dermal  fibroblasts were  grown  to  confluence and  an  in vitro 
wound was produced using a sterile scraper. 0.1 μg/ml, 1 μg/ml or 5 μg/ml of 
RJ was treated immediately after wounding. Migration was monitored for up to 48 
hrs.  Some  fields  were  photographed  immediately  after  wounding.  Bold  lines 
represented  in  vitro  scratch  and  thin  lines  represent  the  migration  front.  A 
representative experiment is shown. (B) Histograms indicate the average coverage 
of scratch wounds widths in % relative to baseline wound width  at 4, 8 and 20 
hrs after Royal Jelly treatments. The % of wound coverage was measured using 
scan image. Values are mean ± SE (n = 9). Means with different letters at each time 
differ  P < 0.05. 
A.HPTLC
B. HPLC
Fig. 3. RJ regulated lipid composition in normal human dermal fibroblasts. 
Normal  human  fibroblasts  were  grown  to  confluence  and  an  in vitro w o u n d  w a s 
produced using a sterile scraper. 0.1 μg/ml, 1 μg/ml or 5 μg/ml of RJ was treated 
for 24 hrs immediately after wounding. Total lipids were extracted and the altered 
level of lipid composition were analyses by HPTLC (A) and HPLC (B). Values are 
mean ± SE  (n = 9).  Means  with  different  letters  at  each  differ  P < 0.05.  GC  ; 
Glucosylceramide,  TG  ;  Triglyceride.
wound coverage was significantly increased for HDFn (data not 
shown; 79.4 ± 3.6 for 1 ug/ml RJ; 78.4 ± 5.4 for 5 ug/ml RJ) 
as compared to the medium-only treated control group. However, 
after 4 hrs wound coverage for HDFn treated with 0.1 ug/ml, 
1 ug/ml, or 5 ug/ml RJ was similar to that of the control group. 
Additionally, overall wound coverage in HDFn (70-80%) after 
48 hrs of treatment with 0.1 ug/ml, 1 ug/ml, or 5 ug/ml RJ was 
similar to that of the control group. 
Effects of RJ on lipids in HDFn as measured by HPTLC and 
HPLC
We showed that lipid composition in HDFn was altered by 
RJ. When the lipid classes within the fibroblasts were assessed 
at 8 hrs after treatment with RJ, the level of cholesterol revealed 
the most noteworthy change in wound coverage in the groups 
treated with 0.1 ug/ml and 5 ug/ml RJ (Fig. 3A). Although TG 
tended to decrease with 0.1 ug/ml and 5 ug/ml RJ, no significant 
difference was observed. Furthermore, no significant changes 
were noted compared to the control with regard to the levels 
of ceramides, glycosylceramides, and TG following treatment 
with 0.1 ug/ml, 1 ug/ml, or 5 ug/ml RJ (Fig. 3A). We next used 
RP-HPLC to analyze HDFn following 8 hrs of treatment with 
RJ. No changes in the sphingosine level were noted with any 
concentration of RJ at 8 hrs (Fig. 3B). However, we did observe 
a dose-dependent increase in the level of sphinganine. This 
increase in sphinganine appeared to have the greatest effect on 
wound coverage following application of RJ at 5 ug/ml. In our 
experiment, the observed increase in sphinganine (sphingoid 
bases: sphingosine and sphinganine) was likely due to an up 
regulation in sphingolipid metabolism, in particular with the 
enzyme that catalyzes the condensation of sphinganine and fatty 
acyl-CoA to form dihydroceramides, which are rapidly oxidized 
to form lipids. This increase in the level of sphinganines appears 
to play a role in the wound-coverage enhancing effects of RJ 
in HDFn. This result, in conjunction with the observed decrease 
in cholesterol content, demonstrates a dose-dependent effect of 
RJ in the wound healing process (Fig. 2 and 3).366 Royal jelly enhances wound healing process
Discussion
In this study, the cutaneous effects of RJ were evaluated in 
an in vitro wound produced by a sterile scraper. We investigated 
the effect of RJ on the migration of human dermal fibroblasts 
(HDFn). In preliminary dose-dependence experiments using RJ, 
varying concentrations of 0.1 ug/ml, 1 ug/ml, or 5 ug/ml were 
shown to have > 100% cell viability by MTT assay (Fig. 1). The 
migration of fibroblasts is the initial response in the formation 
of new tissue in the wound healing process of skin [24,25]. 
Migration was monitored for up to 48 hrs. RJ at concentrations 
of 0.1 ug/ml, 1 ug/ml, and 5 ug/ml demonstrated improved wound 
coverage with HDFn at 20 hrs in an in vitro migration assay. 
Concentrations of RJ at 0.1 ug/ml, 1 ug/ml, and 5 ug/ml were 
used in the present study given the evidence that they improved 
wound coverage with HDFn in an in vitro migration assay after 
48 hrs (Fig. 2, 3). When 5 ug/ml of RJ was applied for 8 hrs, 
wound coverage of HDFn was significantly increased compared 
to the control group (Fig. 2). However, the beneficial effects of 
RJ were not observed at concentrations of 0.1 ug/ml and 1 ug/ml 
after 8 hrs. Additionally, these concentrations were not found 
to significantly alter lipid levels in HDFn after 8 hrs. In contrast, 
TG and cholesterol levels were significantly decreased in HDFn 
after treatment with 5 ug/ml of RJ, as compared to the control group 
(Fig. 3A). Despite a dose-dependent increase in sphinganine, no 
significant changes in the level of sphingosine were noted with 
any concentration of RJ after 8 hrs (Fig. 3B). Given the apparent 
functional importance of alterations in lipid content in facilitating 
the migration of HDFn during wound healing, we evaluated the 
lipid composition of HDFn after 8 hrs of treatment with RJ at 
a concentration of 5 ug/ml. Although the levels of ceramides, 
glucosylceramides, and TG were not altered, the cholesterol level 
was observed to be significantly decreased after treatment with 
5 ug/ml RJ (Fig. 3A). In contrast to our results, previous reports 
found that in cultured skin substitutes grown in vitro the levels 
of cholesterol and free fatty acids were increased during the 
healing process with grafting [10,26]. An increase in the levels 
of lipids in HDFn, in particular sphingolipids such as ceramides 
and glucosylceramides, has been noted to occur in the wound 
healing process [27,28]. Also, increases in the levels of 
glucosylceramides and ceramides were highly distinct [26,29]. 
However, despite a dose-dependent increase in sphinganine, no 
alterations in sphingosine levels were noted with any 
concentration of RJ in our investigation (Fig. 3B). This positive 
association of increased composition of sphingoid bases with 
enhanced migration of HDFn following treatment with 5 ug/ml 
RJ is concordant with the results of previous studies of cultured 
skin substitutes, in which the levels of glucosphingolipids and 
acylglucosylceramides were increased after the use of grafting 
in wound healing [30,31]. These findings, together with reports 
that reductions in lipid composition play a role in wound healing, 
suggest that an increase in the composition of sphingolipids 
enhances wound coverage. 
Recently, evidence suggests that sphinganine (without a 
4,5-trans double bond) has a greater apoptotic potency than 
sphingosine (with a 4,5-trans double bond). Sphinganine might 
increase cellular cAMP to induce the differentiation of stem cells 
into normal adult cells. Additionally, sphingoid bases function 
as second messengers in signal transduction pathways, inhibiting 
cell proliferation and inducing apoptosis in human cancer cells 
[32,33]. It is uncertain whether a sphingosine or sphinganine 
backbone plays a role in mediating the anti-proliferative and 
pro-apoptotic activities of ceramide in cancer cells [34,35]. 
Furthermore, recent evidence suggests that sphingolipids act as 
intracellular mediators in the wound closure process and help 
to restore the barrier function of skin. In fact, upon wound 
formation the intracellular level of a major sphingolipid was 
increased by the activation of ceramide-generating enzymes, such 
as sphingomyelinase, in a stress-associated signaling pathway, 
which in turn increased the expression of peroxisome proliferator- 
activated receptor β (PPAR β) [36,37]. Concomitantly, wound 
formation also increases the generation of PPAR β ligands, which 
include several sphingolipids [31,33,36,38,39]. The resulting 
increase in the level of PPAR β transcription activity ultimately 
accelerates the viability, adhesion, and migration of HDFn during 
the wound healing process [19,26,36,37,40]. 
Royal jelly (RJ), Apis mellifera Linne, is well known as a 
valuable food because of its positive nutritional and physiological 
properties [1,4,6,41]. The principal constituents of RJ include 
water, protein, sugars, lipids, and mineral salts. Royal jelly is 
included in many dermatological preparations, but most prominently 
in those used for skin refreshing and skin regeneration or 
rejuvenation. It is also used in creams or ointments for healing 
burns and other wounds. It is usually included in very small 
dosages (0.05-1%); it is likely that it deteriorates relatively quickly. 
Several of the substances within RJ are pharmacologically active, 
including 10-hydroxy-2-decanoic acid (10HDA) [42,43], royalisin 
[44], and apisin [45]. RJ contains various fatty acids that are 
similar to 10HDA in molecular structure [42,43,46]. A hydroxyl 
fatty acid, 10HDA is the primary bioactive component [42, 
43,47,48] contained in RJ and has been shown to enhance wound 
healing in multiple intensive studies [2]. This fatty acid induces 
the fibroblast cell line, HDFn, to produce transforming growth 
factor-β1 (TGF-β1), which is an important factor for collagen 
production. The collagen production-promoting activity of 10 
HDA can be neutralized by anti-TGF-β1 antibody. As such, 
several mechanisms have been proposed regarding the anti- 
inflammatory and anti-proliferative properties of 10HDA. These 
include increased expression of vascular endothelial growth 
factor (VEGF) [43], transforming growth factor β-1 (TGF β-1), 
and fibroblast growth factor (FGF-1), blocking of the mRNA 
splicing of tumor necrosis factor (TNF-α) and collagenase 
(MMP-1), and inhibition of the biosynthesis of lipoxygenase and 
cycloxygenase metabolites [42,43]. TGF β has been shown to 
act on human dermal fibroblasts at the pretranslational level by 
stimulating the accumulation of fibronectin and type 1 procollagen Juyoung Kim et al. 367
mRNA [49]. The sum of the activities exerted by these hydroxyl 
fatty acids may enhance collagen production and promote wound 
healing. It has been shown that 10HDA increases collagen 
production in vivo and in vitro and that it can provide protective 
anti-oxidative effects in photodamaged skin, increase the level 
of hyaluronic acid, and increase the quantity and quality of elastin 
fiber tissue. Propyl hydroxylase and lysyl hydroxylase are the 
key enzymes in collagen synthesis, and they work by the 
hydroxylating proline and lysine residues in the procollagen 
peptide. Although it is well established that 10HDA performs 
various functions in the skin, if and how influences of other 
molecules are still in doubt. Proteins and sugars make up the 
largest fractions of RJ. Proteins account for 73.9% of the 
nitrogenous substances in RJ and four of the six major proteins 
[50] are glycoproteins [45]. In a previous study, the glycoprotein 
fraction was shown to enhance wound healing in hairless mice 
within 8 days of injury by increasing cell proliferation [51]. RJ 
also contains monosaccahrides, such as pentose and galactose 
[50]. Protein-nitrogen makes up a larger percentage of the 
water-soluble nitrogen in RJ than amino nitrogen. Furthermore, 
some of the proteins in RJ are glycoproteins that contain mannose 
and glucose [52]. Carboxylic acids are the primary ether extract 
components in RJ. As such, RJ may stimulate increased collagen 
production and enhance the deposition of collagen in the dermis, 
thus facilitating wound healing. 
This study demonstrated the novel finding that a 5 ug/ml 
concentration of decocted RJ enhances the migration of human 
fibroblasts and increase the level of sphingolipids in an in vitro 
wound healing model. To more fully evaluate the role of RJ 
in wound healing, future investigations will need to explore the 
effects of various concentrations of RJ on the enhancement of 
wound healing and sphingolipids content. 
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